» Articles » PMID: 19223464

Subcellular Localization of Glycogen Synthase Kinase 3beta Controls Embryonic Stem Cell Self-renewal

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2009 Feb 19
PMID 19223464
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT1), and c-myc have well-established roles in promoting the maintenance of murine embryonic stem cells (mESCs). In contrast, the activity of glycogen synthase kinase 3beta (GSK3beta), a negatively regulated target of AKT1 signaling, antagonizes self-renewal. Here, we show that PI3K/AKT1 signaling promotes self-renewal by suppressing GSK3beta activity and restricting its access to nuclear substrates such as c-myc. GSK3beta shuttles between the cytoplasm and nucleus in mESCs but accumulates in the cytoplasm in an inactive form due to AKT1-dependent nuclear export and inhibitory phosphorylation. When PI3K/AKT1 signaling declines following leukemia inhibitory factor withdrawal, active GSK3beta accumulates in the nucleus, where it targets c-myc through phosphorylation on threonine 58 (T58), promoting its degradation. Ectopic nuclear localization of active GSK3beta promotes differentiation, but this process is blocked by a mutant form of c-myc (T58A) that evades phosphorylation by GSK3beta. This novel mechanism explains how AKT1 promotes self-renewal by regulating the activity and localization of GSK3beta. This pathway converges on c-myc, a key regulator of mESC self-renewal.

Citing Articles

Multi-signal regulation of the GSK-3β homolog Rim11 controls meiosis entry in budding yeast.

Kociemba J, Solvsten Jorgensen A, Tadic N, Harris A, Sideri T, Chan W EMBO J. 2024; 43(15):3256-3286.

PMID: 38886580 PMC: 11294583. DOI: 10.1038/s44318-024-00149-7.


Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-β protein sensing.

Legier T, Rattier D, Llewellyn J, Vannier T, Sorre B, Maina F Nat Commun. 2023; 14(1):349.

PMID: 36681697 PMC: 9867713. DOI: 10.1038/s41467-023-35965-8.


BRD4 and MYC: power couple in transcription and disease.

Kotekar A, Singh A, Devaiah B FEBS J. 2022; 290(20):4820-4842.

PMID: 35866356 PMC: 9867786. DOI: 10.1111/febs.16580.


Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies.

Martelli A, Paganelli F, Evangelisti C, Chiarini F, McCubrey J Cells. 2022; 11(11).

PMID: 35681507 PMC: 9180032. DOI: 10.3390/cells11111812.


Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability.

Yao R, Zhang M, Zhou J, Liu L, Zhang Y, Gao J Cell Commun Signal. 2022; 20(1):73.

PMID: 35619182 PMC: 9137135. DOI: 10.1186/s12964-022-00868-6.


References
1.
Fraser E, Young N, Dajani R, Franca-Koh J, Ryves J, Williams R . Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J Biol Chem. 2001; 277(3):2176-85. DOI: 10.1074/jbc.M109462200. View

2.
Wiechens N, Heinle K, Englmeier L, Schohl A, Fagotto F . Nucleo-cytoplasmic shuttling of Axin, a negative regulator of the Wnt-beta-catenin Pathway. J Biol Chem. 2003; 279(7):5263-7. DOI: 10.1074/jbc.M307253200. View

3.
Takahashi K, Murakami M, Yamanaka S . Role of the phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells. Biochem Soc Trans. 2005; 33(Pt 6):1522-5. DOI: 10.1042/BST0331522. View

4.
Kim J, Chu J, Shen X, Wang J, Orkin S . An extended transcriptional network for pluripotency of embryonic stem cells. Cell. 2008; 132(6):1049-61. PMC: 3837340. DOI: 10.1016/j.cell.2008.02.039. View

5.
Bijur G, Jope R . Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem. 2001; 276(40):37436-42. PMC: 1973163. DOI: 10.1074/jbc.M105725200. View